REACH and CLP Responsibility Matrix for European Private-Label Chemicals

Private labelling can make an ordinary chemical purchase into a controlled supply-chain project. A buyer may ask a manufacturer to fill an established product into a branded pack, a distributor to arrange a relabelled supply, or a formulator to make a customer-specific mixture. Those commercial descriptions do not by themselves establish the party’s legal role. For a REACH private label chemical responsibility matrix, start with the facts that affect role: who is established in the EU or EEA, whether the company imports, whether anyone changes composition or transfers product, who places the supplied substance or mixture on the market, and which information travels with it.

This is a procurement and evidence-control guide, not a determination of legal obligations for a particular product or Member State. REACH and CLP responsibilities depend on the actual activity, supply chain, product and jurisdiction. Before offering a private-label substance or mixture, the responsible organisation should obtain qualified regulatory advice where needed and document its conclusion. The goal is to prevent a brand owner, distributor, filler and manufacturer from each assuming someone else owns a critical release decision.

Map activity before assigning a role

Build the matrix from the physical and commercial route, not from job titles. Record each entity, establishment location, contractual function, product identity, whether it imports into the EU/EEA, whether it blends, dilutes, transfers or repackages, and whether it supplies onward. ECHA explains that a distributor that only stores and distributes is not a downstream user, but it has supply-chain information duties. If that distributor transfers or dilutes a chemical, it becomes a downstream user. ECHA also identifies refillers that transfer substances or mixtures to another container during repackaging or rebranding as downstream users.

A practical matrix has rows for the non-EU manufacturer where relevant, EU importer, only representative where relevant, formulator, filler or refiller, distributor, brand owner and customer. Columns should show the activity, proposed role, owner of the evidence, owner of customer communication, record location and approval status. Do not use it to relabel an entity into a more convenient role. Use it to expose gaps that need review before the product, packaging artwork or quotation is released.

Link the commercial request to the exact material and intended route through the product portfolio, then retain the approved matrix with controlled documentation. A product name, CAS reference or label artwork alone is not sufficient evidence that every supplied component, concentration and supply-chain function has been assessed.

Separate REACH supply-chain evidence from CLP hazard communication

REACH and CLP interact, but they do not create one interchangeable paperwork file. REACH controls include registration and supply-chain communication requirements; CLP concerns classification, labelling and packaging. ECHA states that suppliers—including manufacturers, importers, downstream users and distributors—must communicate identified hazards under CLP before placing hazardous substances or mixtures on the EU market. The responsible party needs a documented basis for the actual material supplied.

For a private-label project, keep separate but connected evidence folders. A REACH folder can capture supplier identity, substance or mixture identifiers, relevant registration or only-representative statements where supplied, intended uses communicated upstream, current SDS or extended SDS, and decisions on the buyer’s role. A CLP folder can capture classification rationale, label elements, artwork approval, packaging configuration, poison-centre notification status where applicable and release control. The matrix should name an owner for each folder and the escalation path when an upstream document is incomplete or conflicts with proposed sales copy.

Do not turn a supplier’s registration number, a generic compliance declaration or an old SDS into a universal assurance. The responsible organisation must evaluate whether the document concerns the exact substance or mixture, concentration, legal entity, market and supply route. Customer-specific branding can make version control more—not less—important.

Classify the exact mixture, not the commercial concept

ECHA describes self-classification as a core CLP principle for suppliers. Hazardous mixtures are self-classified before they are placed on the EU market; a mixture may be assessed using information on the mixture, its constituents, or similar tested mixtures under the applicable criteria. A private label does not change the chemistry, but it can change who needs to confirm that the classification, label and safety communication match the exact supplied mixture.

Ask for a controlled composition and classification evidence package from the technically responsible party. The release record should identify the product code, formulation or concentration range, revision, constituent information needed for the determination, classification outcome, label elements, SDS revision, pack sizes and destinations. Treat an ingredient SDS as input evidence, not automatically as the final classification of the mixture. Similarly, do not copy a competitor’s label or classify from a marketing phrase such as “industrial cleaner.”

Where a company only distributes an unchanged substance or mixture, ECHA notes that distributors may use the classification provided in the SDS. That point is not a shortcut for an altered product. A different concentration, added dye, dilution, blend, refill or product identity can require a fresh role and classification review. Keep the review tied to the item actually placed on the market.

Release labels, SDSs and destination data together

A controlled private label SDS and label control Europe process releases one matched set: label artwork, current SDS, product identifier, supplier details, pack configuration and destination-language requirements. ECHA’s distributor guidance says that a distributor of a hazardous substance or mixture must provide an SDS or extended SDS in the respective national language and include nationally required information. Destination requirements can vary, so record the delivery country and purchaser before finalising the document package.

Use a release checklist with the product code; label and SDS revisions; classification decision; language; supplier and emergency contact fields; pack and closure; market; document owner; and effective date. Check that the same identity appears on the purchase order, container label, SDS and transport documents. The document centre and packaging controls can support a documented request for the current commercial configuration, without implying that an online file replaces a shipment-specific review.

Make information flow an operating control

Private-label agreements should assign upstream and downstream information flow in practical terms. ECHA says distributors have a central responsibility to pass information between manufacturers, formulators and users; customers may communicate new hazardous-property information and information that calls risk-management measures in an SDS into question. Translate that into named contacts, an intake route, a decision owner and a response record. A generic mailbox that is never reviewed is not an effective control.

For example, a customer report about unexpected handling conditions should be logged, triaged and sent to the responsible technical or regulatory party. A supplier’s new classification, formulation range, SDS revision, package component or manufacturing-site notification should enter change review before the next customer release. The buyer should not promise that every change is immaterial; the supplier should not silently treat a brand-artwork approval as acceptance of a different mixture or label basis.

Use change control to keep the matrix current

Set triggers for a private-label review: a different legal entity, import route, only representative, formulation or concentration, constituent source, classification, SDS, label language, package, closure, fill location, customer use or destination. Define whether the change requires a document update, classification reassessment, customer communication, commercial approval or a hold. Link the approved result to batch traceability so a released lot can be associated with the applicable document and artwork revision.

Periodic checks matter too. Reconfirm the legal entities and activities in the route, sample the released label and SDS against the matrix, and make sure obsolete artwork cannot be used. Record the evidence reviewed and the conclusion rather than merely ticking “REACH/CLP checked.” This creates a usable audit trail while avoiding unsupported regulatory declarations.

Private-label responsibility checklist

• Map every entity, EU/EEA establishment, import route and physical activity.
• Distinguish simple distribution from formulation, dilution, transfer or refilling.
• Assign owners for REACH evidence, CLP classification, label artwork, SDS and customer communication.
• Control the exact mixture identity, formulation revision, pack and destination.
• Keep classification inputs separate from the final mixture determination.
• Release a matched label, SDS and destination-language package.
• Log upstream and downstream safety information with named decision owners.
• Trigger documented review for changes to role, composition, classification, pack or market.

A sound CLP private label mixture classification workflow makes roles visible before commercial release; it does not replace product-specific legal analysis. For a proposed European supply route, review European market support, quality controls and request a private-label documentation review with the product, activity, pack and intended destination.